A detailed history of Woodard & CO Asset Management Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Woodard & CO Asset Management Group Inc holds 8,190 shares of ABT stock, worth $944,307. This represents 0.23% of its overall portfolio holdings.

Number of Shares
8,190
Previous 8,190 -0.0%
Holding current value
$944,307
Previous $851,000 9.64%
% of portfolio
0.23%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $12,418 - $14,900
-130 Reduced 1.56%
8,190 $793,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $13,101 - $14,597
130 Added 1.59%
8,320 $907,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $29,702 - $35,900
-291 Reduced 3.43%
8,190 $890,000
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $16,076 - $19,604
141 Added 1.69%
8,481 $1 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $14,441 - $17,682
-125 Reduced 1.48%
8,340 $1.17 Million
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $14,582 - $16,132
125 Added 1.5%
8,465 $1 Million
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $31,080 - $33,868
-296 Reduced 3.43%
8,340 $913,000
Q2 2020

Jul 24, 2020

BUY
$76.57 - $98.0 $15,313 - $19,600
200 Added 2.37%
8,636 $790,000
Q1 2020

Apr 27, 2020

BUY
$62.82 - $91.86 $18,594 - $27,190
296 Added 3.64%
8,436 $666,000
Q3 2019

Oct 22, 2019

BUY
$81.84 - $88.74 $49,104 - $53,244
600 Added 7.96%
8,140 $681,000
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $44,384 - $50,280
-677 Reduced 8.24%
7,540 $545,000
Q3 2018

Oct 26, 2018

BUY
$60.81 - $73.36 $4,682 - $5,648
77 Added 0.95%
8,217 $603,000
Q4 2017

Feb 16, 2018

BUY
$53.68 - $57.47 $436,955 - $467,805
8,140
8,140 $464,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Woodard & CO Asset Management Group Inc Portfolio

Follow Woodard & CO Asset Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.